Popular Articles

Antiretrovirals Can Be Used To Prevent Spread Of HIV/AIDS, Model Shows
In addition to acting as life-saving therapy to people living with HIV/AIDS, WHO researchers say antiretrovirals (ARVs) may also be able to prevent the spread of HIV, Health-e/allAfrica.com reports. Reuben Granich, of the WHO, used a model to estimate the use of ARVs for the prevention of HIV transmission, and presented his findings to delegates gathered at the 5th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention meeting in Cape Town, South Africa (Thom, 7/20).
diet pills Prezzi dentisti croazia
WHO Recommends Vaccine Makers Move Forward In Mass Production Of H1N1 Vaccine
"Saying the new H1N1 [swine flu] virus is "unstoppable", the WHO gave drug makers a full go-ahead to manufacture vaccines against the pandemic influenza strain on Monday and said healthcare workers should be the first to get one," Reuters reports (Fox, 7/14). This, as "Britain, Brazil, Colombia, Mexico, the Philippines and Thailand all reported deaths on Monday, while Saudi Arabia shut an international school after 20 students were diagnosed with the A(H1N1) virus," AFP/Google.com reports (7/13). "As of last week, the WHO had reported nearly 95,000 laboratory-confirmed cases of pandemic flu and 429 deaths," the Los Angeles Times reports (Maugh, 7/14).
News of the day
Cancer Specialists Back New Treatment For UK Patients
Trial reports of the Evolife range of products in France have pointed to significant benefits and enhanced quality of life for cancer patients who use the products before, during and after chemo or radiotherapy treatment. Evolife is a natural range of cosmetics that is 100% dedicated to the support care of cancer patients.
Mental Health

Turkish Ministry Of Health Purchases Two CyberKnife(R) Systems - Expands Patient Access To The Benefits Of Whole Body Radiosurgery

Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced that the Turkish Ministry of Health has purchased two CyberKnife(R) Robotic Radiosurgery Systems for installation in Ankara and Istanbul, Turkey. Turkey"s first CyberKnife System was installed at Anadolu Medical Center in January 2005. A second system was installed in Turkey at Hacettepe University Hospital in May 2007. In addition to the two recent purchases by the Ministry of Health, a fifth System for installation within Turkey was recently purchased by Istanbul University, Oncology Institute, a leading academic institution in Capa district, Istanbul. The sales of these Systems were coordinated by local distributor Radontek Ltd. "The Turkish Ministry of Health"s purchase of two CyberKnife Systems is further validation of the System"s worldwide clinical acceptance, particularly amongst government institutions," said Euan S. Thomson, Ph.D., president and CEO of Accuray Incorporated. "Full body radiosurgery with the CyberKnife System has truly established itself as a viable treatment alternative for cancer patients around the world." The CyberKnife Systems for Ankara and Instanbul were purchased by the Turkish Ministry of Health for Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi (Ankara) and Dr. Lutfu Kirdar Kartal Egitim ve Arastirma Hastanesi (Istanbul). About the CyberKnife(R) Robotic Radiosurgery System The CyberKnife Robotic Radiosurgery System is the world"s only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames. Accuray Incorporated


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):